Verrica Pharmaceuticals Inc (VRCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -42,381 | -17,579 | -6,589 | -24,487 | -18,555 |
| Depreciation Amortization | 619 | 409 | 202 | 826 | 614 |
| Accounts receivable | -3,946 | N/A | N/A | -487 | -419 |
| Accounts payable and accrued liabilities | 1,623 | 1,502 | 14 | -338 | -708 |
| Other Working Capital | 4,992 | 5,273 | 703 | -1,800 | -1,384 |
| Other Operating Activity | 15,023 | 1,136 | 1,080 | 7,636 | 6,756 |
| Operating Cash Flow | $-24,070 | $-9,259 | $-4,590 | $-18,650 | $-13,696 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 59,008 | 52,008 |
| PPE Investments | -135 | -70 | -11 | -482 | -236 |
| Purchase Of Investment | N/A | N/A | N/A | -4,485 | -4,485 |
| Investing Cash Flow | $-135 | $-70 | $-11 | $54,041 | $47,287 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 44,105 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | -43,754 | -43,754 |
| Common Stock Issued | 30,308 | 30,308 | 30,308 | 26,901 | 26,901 |
| Other Financing Activity | -173 | -112 | -28 | -17 | -17 |
| Financing Cash Flow | $74,240 | $30,196 | $30,280 | $-16,870 | $-16,870 |
| Beginning Cash Position | 34,273 | 34,273 | 34,273 | 15,752 | 15,752 |
| End Cash Position | 84,308 | 55,140 | 59,952 | 34,273 | 32,473 |
| Net Cash Flow | $50,035 | $20,867 | $25,679 | $18,521 | $16,721 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,070 | -9,259 | -4,590 | -18,650 | -13,696 |
| Capital Expenditure | -135 | -70 | -11 | -482 | -236 |
| Free Cash Flow | -24,205 | -9,329 | -4,601 | -19,132 | -13,932 |